| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Original Research Communications |
1 From the Laboratory for Human Nutrition, Institute of Food Science, Swiss Federal Institute of Technology, Rüschlikon, Switzerland; the Department of Pediatric Gastroenterology and Nutrition, Warsaw University Medical School, Dzialdowska, Poland; and Nestlé Research Centre Lausanne, Lausanne, Switzerland.
Background: Infant cereals are commonly fortified with insoluble iron compounds with low relative bioavailability, such as ferric pyrophosphate, because of organoleptic changes that occur after addition of water-soluble iron sources.
Objective: Our objective was to compare iron bioavailability from ferric pyrophosphate with an alternative iron source that is soluble in dilute acid, ferrous fumarate, and to evaluate the influence of ascorbic acid on iron bioavailability from ferrous fumarate in infants.
Design: Iron bioavailability was measured as the incorporation of stable iron isotopes into erythrocytes 14 d after administration of labeled test meals (25 g dry wheat and soy infant cereal, 100 g water, and 2.5 mg Fe as [57Fe]ferric pyrophosphate or [57Fe]ferrous fumarate). Ascorbic acid was added to all test meals (25 mg in study 1 or 25 or 50 mg in study 2). Infants were fed each test meal on 4 consecutive days under standardized conditions. The 2 different test meals within each study were administered 2 wk apart in a crossover design.
Results: Geometric mean iron bioavailability was significantly higher from [57Fe]ferrous fumarate than from [57Fe]ferric pyrophosphate [4.1% (range: 1.7–14.7%) compared with 1.3% (range: 0.7–2.7%); n = 8, P = 0.008]. In this study, doubling the ascorbic acid content did not further enhance iron bioavailability; the geometric means (range) were 3.4% (1.9–6.6%) and 4.2% (1.2–18.7%) for the test meals with 25 and 50 mg ascorbic acid added, respectively (n = 9).
Conclusion: Iron bioavailability from iron-fortified infant cereals can be improved by using an iron compound with high relative bioavailability and by ensuring adequate ascorbic acid content of the product.
Key Words: Iron • infants • ferrous fumarate • ferric pyrophosphate • bioavailability • stable isotopes • infant cereal
This article has been cited by other articles:
|
|
 |
|
  S. Navas-Carretero, A.M. Perez-Granados, B. Sarria, S. Schoppen, and M.P. Vaquero Iron Bioavailability from Pate Enriched with Encapsulated Ferric Pyrophosphate or Ferrous Gluconate in Rats Food Science and Technology International, April 1, 2007; 13(2): 159 - 163. [Abstract] [PDF]
|
|
|
|
 |
|
 S. H. Zlotkin, C. Schauer, S. O. Agyei, J. Wolfson, M. C. Tondeur, K. P. Asante, S. Newton, R. E. Serfass, and W. Sharieff Demonstrating Zinc and Iron Bioavailability from Intrinsically Labeled Microencapsulated Ferrous Fumarate and Zinc Gluconate Sprinkles in Young Children J. Nutr., April 1, 2006; 136(4): 920 - 925. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. B. Perez-Exposito, S. Villalpando, J. A. Rivera, I. J. Griffin, and S. A. Abrams Ferrous Sulfate Is More Bioavailable among Preschoolers than Other Forms of Iron in a Milk-Based Weaning Food Distributed by PROGRESA, a National Program in Mexico J. Nutr., January 1, 2005; 135(1): 64 - 69. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Wegmuller, M. B. Zimmermann, D. Moretti, M. Arnold, W. Langhans, and R. F. Hurrell Particle Size Reduction and Encapsulation Affect the Bioavailability of Ferric Pyrophosphate in Rats J. Nutr., December 1, 2004; 134(12): 3301 - 3304. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. C Tondeur, C. S Schauer, A. L Christofides, K. P Asante, S. Newton, R. E Serfass, and S. H Zlotkin Determination of iron absorption from intrinsically labeled microencapsulated ferrous fumarate (sprinkles) in infants with different iron and hematologic status by using a dual-stable-isotope method Am. J. Clinical Nutrition, November 1, 2004; 80(5): 1436 - 1444. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. B Zimmermann, R. Wegmueller, C. Zeder, N. Chaouki, F. Rohner, M. Saissi, T. Torresani, and R. F Hurrell Dual fortification of salt with iodine and micronized ferric pyrophosphate: a randomized, double-blind, controlled trial Am. J. Clinical Nutrition, October 1, 2004; 80(4): 952 - 959. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. A Sarker, L. Davidsson, H. Mahmud, T. Walczyk, R. F Hurrell, N. Gyr, and G. J Fuchs Helicobacter pylori infection, iron absorption, and gastric acid secretion in Bangladeshi children Am. J. Clinical Nutrition, July 1, 2004; 80(1): 149 - 153. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. R. Lynch and R. J. Stoltzfus Iron and Ascorbic Acid: Proposed Fortification Levels and Recommended Iron Compounds J. Nutr., September 1, 2003; 133(9): 2978S - 2984. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Davidsson Approaches to Improve Iron Bioavailability from Complementary Foods J. Nutr., May 1, 2003; 133(5): 1560S - 1562. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Kastenmayer, G. L. Czarnecki-Maulden, and W. King Mineral and Trace Element Absorption from Dry Dog Food by Dogs, Determined Using Stable Isotopes J. Nutr., June 1, 2002; 132(6): 1670S - 1672. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. F. Hurrell Fortification: Overcoming Technical and Practical Barriers J. Nutr., April 1, 2002; 132(4): 806S - 812. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Davidsson, T. Dimitriou, E. Boy, T. Walczyk, and R. F Hurrell Iron bioavailability from iron-fortified Guatemalan meals based on corn tortillas and black bean paste Am. J. Clinical Nutrition, March 1, 2002; 75(3): 535 - 539. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Zlotkin, P. Arthur, K. Y. Antwi, and G. Yeung Treatment of anemia with microencapsulated ferrous fumarate plus ascorbic acid supplied as sprinkles to complementary (weaning) foods Am. J. Clinical Nutrition, December 1, 2001; 74(6): 791 - 795. [Abstract] [Full Text]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
